VELLFERON (Wellferon).

     ? Interferon-n 1, LM cells in culture limfoblastoidnyh Namalva.

     For actions and side effects similar to human interferon leykotsitarnomu injection.

     Applied for chronic hepatitis B and C, hemoblastosis, skin lymphoma, thrombocytopenia, kidney cancer, malignant melanoma, disseminated form of solid tumors.

     Assign subcutaneously or intramuscularly.

     Adults with chronic hepatitis type B on 10000000 -15 000000 IU 3 times a week for 12 weeks; In chronic hepatitis C-5000000 on IU over 48 weeks; In kidney cancer-3000000 IU daily, increasing dose to 30000000 -60 000000 IU per week; in chronic mieloleykoze - 3000000 IU daily for 3 weeks, followed by maintenance dose of providing the level of leukocyte 2 h109 / l to 5 h109 / L rate 6 months; when volosatokletochnom leukemia-3000000 IU daily for 12-16 weeks, then three times a week for 3 months or more.

     Contraindications : mental illness, pregnancy, breast-feeding; For patients with hepatitis, heart disease, disruption of the liver and kidney, liver cirrhosis asthma.

     Product : injection in vials on 10000000 and 3000000  IU.

     Storage : List B.

Materials allowed to copy only with the active hyperlink to the handbook of medicines